Results of first salvage therapy for patients refractory to a fludarabine regimen in chronic lymphocytic leukemia

Leukemia and Lymphoma

Volumn 43, Issue 9, 2002, Pages 1755-1762

  Keating, M J ^a   O'Brien, S ^a   Kontoyiannis, D ^a   Plunkett, W ^a   Koller, C ^a   Beran, M ^a   Lerner, S ^a   Kantarjian, H ^a  

^a UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

Author keywords

Chronic lymphocytic leukemia; Fludarabine regimen; Refractory CLL; Salvage therapy

Indexed keywords

ALEMTUZUMAB; ALKYLATING AGENT; ANTHRACYCLINE; CYCLOPHOSPHAMIDE; CYTARABINE; DEXAMETHASONE; DOXORUBICIN; ENLOPLATIN; FLUDARABINE PHOSPHATE; GRANULOCYTE COLONY STIMULATING FACTOR; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; GUANINE ARABINOSIDE; IDARUBICIN; MITOXANTRONE; PACLITAXEL; PLATINUM; PREDNISONE; PURINE DERIVATIVE; TOPOTECAN; VINCRISTINE;

ACID FAST BACTERIUM; ADULT; AGED; ARTICLE; BRONCHITIS; CAUSE OF DEATH; CELLULITIS; CHRONIC LYMPHATIC LEUKEMIA; CONTROLLED STUDY; DISEASE ASSOCIATION; DRUG EFFICACY; DRUG SENSITIVITY; FEMALE; FEVER; GRAM NEGATIVE INFECTION; GRAM POSITIVE BACTERIUM; HERPES SIMPLEX; HERPES ZOSTER; HUMAN; LEGIONELLA; LEUKEMIA REMISSION; MAJOR CLINICAL STUDY; MALE; MORBIDITY; MYCOSIS; OPPORTUNISTIC INFECTION; PNEUMOCYSTIS CARINII; PNEUMONIA; PRIORITY JOURNAL; PROBABILITY; PROGNOSIS; SALVAGE THERAPY; SEPTICEMIA; SINUSITIS; SURVIVAL TIME; URINARY TRACT INFECTION;

ADULT; AGED; AGED, 80 AND OVER; ANTINEOPLASTIC AGENTS; ANTINEOPLASTIC AGENTS, ALKYLATING; CYCLOPHOSPHAMIDE; DRUG RESISTANCE, NEOPLASM; FEMALE; HUMANS; LEUKEMIA, LYMPHOCYTIC, CHRONIC; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; SALVAGE THERAPY; TIME FACTORS; VIDARABINE;

EID: 0036335916     PISSN: 10428194     EISSN: None     Source Type: Journal    
DOI: 10.1080/1042819021000006547     Document Type: Article

References (36)

1. "Biweekly chlorambucil treatment of chronic lymphocytic leukemia"
2. "Combination chemotherapy with cyclophosphamide, vincristine, and prednisone in the treatment of refractory chronic lymphocytic leukemia"
3. "The treatment of chronic lymphocytic leukemia with COP chemotherapy"
4. "Long-term results of CAP therapy in chronic lymphoctyic leukemia"
5. "Effectiveness of "CHOP" Regimen in advanced untreated chronic lymphocytic leukemia"
6. "Multiple agent chemotherapy (POACH) in previously treated and untreated patients with chronic lymphocytic leukemia"
7. "Fludarabine monophosphate: A potentially useful agent in chronic lymphocytic leukemia"
8. "Fludarabine: A new agent with major activity against chronic lymphocytic leukemia"
9. "2-chlorodeoxyadenosine treatment of refractory chronic lymphocytic leukemia"
10. "Low-dose deoxycoformycin in lymphoid malignancy"
11. "Fludarabine: A new agent with marked cytoreductive activity in untreated chronic lymphocytic leukemia"
12. "Multicentre prospective randomised trial of fludarabine versus cyclophosphamide, doxorubicin, and prednisone (CAP) for treatment of advanced-stage chronic lymphocytic leukemia"
13. "A randomized comparison of Fludarabine and chlorambucil for patients with previously untreated chronic lymphocytic leukemia. A CALGB, SWOG, CTG/NCI-C, and ECOG Inter-Group Study"
14. "Allogeneic blood or marrow transplantation for chronic lymphocytic leukaemia: Timing of transplantation and potential effect of fludarabine on acute graft-versus-host disease"
15. "HLA-identical sibling bone marrow transplantation in younger patients with chronic lymphocytic leukemia"
16. "Humanized CD52 monoclonal antibody CAMPATH-1H as firstline treatment in chronic lymphocytic leukemia"
17. "Subcutaneous CAMPATH-1H in fludarabine-resistant/relapsed chronic lymphocytic and B-prolymphocytic leukaemia"
18. "Rituximab dose-escalation trial in chronic lymphocytic leukemia"
19. "Phase I/II study of thrice weekly Rituximab in chronic lymphocytic leukemia (CLL)/small lymphoctyic lymphoma (SLL): A feasible and active regimen"
20. "Long-term follow-up of patients with chronic lymphocytic leukemia treated with fludarabine as a single agent"
21. "Fludarabine and granulocyte colony-stimulating factor (G-CSF) in patients with chronic lymphocytic leukemia"
22. "In vivo "purging" of residual disease in CLL with Campath-1H"
23. "Fludarabine and cyclophosphamide therapy in chronic lymphocytic leukemia"
24. "Fludarabine infusion potentiates arabinosylcytosine metabolism in lymphocytes of patients with chronic lymphocytic leukemia"
25. "Fludarabine plus doxorubicin in previously treated chronic lymphocytic leukemia"
26. "Sequential cis-platinum and fludarabine with or without arabinosyl cytosine in patients failing prior fludarabine therapy for chronic lymphocytic leukemia: A phase II study"
27. "Compound 506 has activity in mature lymphoid leukemias"
28. "Response to 2-chlorodeoxyadenosine in patients with B-cell chronic lymphocytic leukemia resistant to fludarabine"
29. "Lack of effect of 2-chlorodeoxyadenosine therapy in patients with chronic lymphocytic leukemia refractory to fludarabine therapy"
30. "2-chlorodeoxyadenosine for patients with B-cell chronic lymphocytic leukemia resistant to fludarabine"
31. "p53 mutation in B-cell chronic lymphocytic leukemia is associated with drug resistance and is independent of MDR1/MDR3 gene expression"
32. "Molecular cytogenetic analysis of B-cell chronic lymphocytic leukemia"
33. "Is the mdr1 gene relevant in chronic lymphocytic leukemia?"
34. "Bcl-2 family proteins in deregulation of apoptosis and chemoresistance in B-CLL"
35. "Mechanism-based rationales for combination therapies of lymphoid malignancies"
36. "Prediction of prognosis following fludarabine used as secondary therapy for chronic lymphocytic leukemia"